Cargando…

Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease

High cryptococcal antigen (CrAg) titers in blood are associated with subclinical meningitis and mortality in CrAg-positive individuals with advanced HIV disease (AHD). We evaluated a novel semiquantitative lateral flow assay (LFA), CryptoPS, that may be able to identify individuals with high CrAg ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tenforde, Mark W., Boyer-Chammard, Timothée, Muthoga, Charles, Tawe, Leabaneng, Milton, Thandi, Rulaganyang, Ikanyeng, Lechiile, Kwana, Rukasha, Ivy, Leeme, Tshepo B., Govender, Nelesh P., Ngidi, Julia, Mine, Madisa, Molloy, Síle F., Harrison, Thomas S., Lortholary, Olivier, Jarvis, Joseph N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771453/
https://www.ncbi.nlm.nih.gov/pubmed/33087436
http://dx.doi.org/10.1128/JCM.02307-20
_version_ 1783629689840992256
author Tenforde, Mark W.
Boyer-Chammard, Timothée
Muthoga, Charles
Tawe, Leabaneng
Milton, Thandi
Rulaganyang, Ikanyeng
Lechiile, Kwana
Rukasha, Ivy
Leeme, Tshepo B.
Govender, Nelesh P.
Ngidi, Julia
Mine, Madisa
Molloy, Síle F.
Harrison, Thomas S.
Lortholary, Olivier
Jarvis, Joseph N.
author_facet Tenforde, Mark W.
Boyer-Chammard, Timothée
Muthoga, Charles
Tawe, Leabaneng
Milton, Thandi
Rulaganyang, Ikanyeng
Lechiile, Kwana
Rukasha, Ivy
Leeme, Tshepo B.
Govender, Nelesh P.
Ngidi, Julia
Mine, Madisa
Molloy, Síle F.
Harrison, Thomas S.
Lortholary, Olivier
Jarvis, Joseph N.
author_sort Tenforde, Mark W.
collection PubMed
description High cryptococcal antigen (CrAg) titers in blood are associated with subclinical meningitis and mortality in CrAg-positive individuals with advanced HIV disease (AHD). We evaluated a novel semiquantitative lateral flow assay (LFA), CryptoPS, that may be able to identify individuals with high CrAg titers in a cohort of AHD patients undergoing CrAg screening. In a prospective cohort of patients with AHD (CD4 cell count, ≤200/μl) receiving CD4 count testing, whole blood was tested for CrAg by CryptoPS and the IMMY LFA; the two assays were conducted by two different operators, each blind to the results of the other assay. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of CryptoPS were assessed against the IMMY LFA as a reference. CryptoPS low-titer (T1 band) and high-titer (T2 band) results were compared with IMMY LFA titers obtained through serial dilution. A total of 916 specimens were tested. The sensitivity of the CryptoPS assay was 61.0% (25/41) (95% confidence interval [95% CI], 44.5 to 75.8%), its specificity was 96.6% (845/875) (95% CI, 95.1 to 97.7%), its PPV was 45.5% (95% CI, 32.0 to 59.4%), and its NPV was 98.1% (95% CI, 97.0 to 98.9%). All (16/16) CryptoPS false-negative results were obtained for samples with IMMY titers of ≤1:160. Of 29 patients (30 specimens) who tested positive by CryptoPS but negative by the IMMY LFA, none developed cryptococcal meningitis over 3 months of follow-up without fluconazole. Median CrAg titers were 1:20 (interquartile range [IQR], 0 to 1:160) in CryptoPS T1-positive samples and 1:2,560 (IQR, 1:1,280 to 1:10,240) in T2-positive samples. We conclude that the diagnostic accuracy of the CryptoPS assay was suboptimal in the context of CrAg screening, with poor sensitivity at low CrAg titers. However, the CryptoPS assay reliably detected individuals with high titers, which are associated with poor outcomes.
format Online
Article
Text
id pubmed-7771453
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-77714532021-06-17 Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease Tenforde, Mark W. Boyer-Chammard, Timothée Muthoga, Charles Tawe, Leabaneng Milton, Thandi Rulaganyang, Ikanyeng Lechiile, Kwana Rukasha, Ivy Leeme, Tshepo B. Govender, Nelesh P. Ngidi, Julia Mine, Madisa Molloy, Síle F. Harrison, Thomas S. Lortholary, Olivier Jarvis, Joseph N. J Clin Microbiol Mycology High cryptococcal antigen (CrAg) titers in blood are associated with subclinical meningitis and mortality in CrAg-positive individuals with advanced HIV disease (AHD). We evaluated a novel semiquantitative lateral flow assay (LFA), CryptoPS, that may be able to identify individuals with high CrAg titers in a cohort of AHD patients undergoing CrAg screening. In a prospective cohort of patients with AHD (CD4 cell count, ≤200/μl) receiving CD4 count testing, whole blood was tested for CrAg by CryptoPS and the IMMY LFA; the two assays were conducted by two different operators, each blind to the results of the other assay. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of CryptoPS were assessed against the IMMY LFA as a reference. CryptoPS low-titer (T1 band) and high-titer (T2 band) results were compared with IMMY LFA titers obtained through serial dilution. A total of 916 specimens were tested. The sensitivity of the CryptoPS assay was 61.0% (25/41) (95% confidence interval [95% CI], 44.5 to 75.8%), its specificity was 96.6% (845/875) (95% CI, 95.1 to 97.7%), its PPV was 45.5% (95% CI, 32.0 to 59.4%), and its NPV was 98.1% (95% CI, 97.0 to 98.9%). All (16/16) CryptoPS false-negative results were obtained for samples with IMMY titers of ≤1:160. Of 29 patients (30 specimens) who tested positive by CryptoPS but negative by the IMMY LFA, none developed cryptococcal meningitis over 3 months of follow-up without fluconazole. Median CrAg titers were 1:20 (interquartile range [IQR], 0 to 1:160) in CryptoPS T1-positive samples and 1:2,560 (IQR, 1:1,280 to 1:10,240) in T2-positive samples. We conclude that the diagnostic accuracy of the CryptoPS assay was suboptimal in the context of CrAg screening, with poor sensitivity at low CrAg titers. However, the CryptoPS assay reliably detected individuals with high titers, which are associated with poor outcomes. American Society for Microbiology 2020-12-17 /pmc/articles/PMC7771453/ /pubmed/33087436 http://dx.doi.org/10.1128/JCM.02307-20 Text en Copyright © 2020 Tenforde et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Mycology
Tenforde, Mark W.
Boyer-Chammard, Timothée
Muthoga, Charles
Tawe, Leabaneng
Milton, Thandi
Rulaganyang, Ikanyeng
Lechiile, Kwana
Rukasha, Ivy
Leeme, Tshepo B.
Govender, Nelesh P.
Ngidi, Julia
Mine, Madisa
Molloy, Síle F.
Harrison, Thomas S.
Lortholary, Olivier
Jarvis, Joseph N.
Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease
title Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease
title_full Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease
title_fullStr Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease
title_full_unstemmed Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease
title_short Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease
title_sort diagnostic accuracy of the biosynex cryptops cryptococcal antigen semiquantitative lateral flow assay in patients with advanced hiv disease
topic Mycology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771453/
https://www.ncbi.nlm.nih.gov/pubmed/33087436
http://dx.doi.org/10.1128/JCM.02307-20
work_keys_str_mv AT tenfordemarkw diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease
AT boyerchammardtimothee diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease
AT muthogacharles diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease
AT taweleabaneng diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease
AT miltonthandi diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease
AT rulaganyangikanyeng diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease
AT lechiilekwana diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease
AT rukashaivy diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease
AT leemetshepob diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease
AT govenderneleshp diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease
AT ngidijulia diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease
AT minemadisa diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease
AT molloysilef diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease
AT harrisonthomass diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease
AT lortholaryolivier diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease
AT jarvisjosephn diagnosticaccuracyofthebiosynexcryptopscryptococcalantigensemiquantitativelateralflowassayinpatientswithadvancedhivdisease